Association between Multimorbidity and COVID-19 Mortality in Qatar: A Cross-Sectional Study
المؤلف | AbouGalala, Khalid |
المؤلف | Elsayed, Basant |
المؤلف | Elmarasi, Mohamed |
المؤلف | Kotob, Mona |
المؤلف | Taha, Reham |
المؤلف | Abbasher, Fardous |
المؤلف | Amarah, Ahmed |
المؤلف | El Hamawi, Mariam |
المؤلف | Albayat, Soha S. |
المؤلف | Abdulmajeed, Jazeel |
المؤلف | Sallam, Mohamed A.H. |
المؤلف | Al-Shamali, Maha H.M. |
المؤلف | Al-Romaihi, Hamad E. |
المؤلف | Bansal, Devendra |
المؤلف | Musa, Omran A.H. |
المؤلف | Farag, Elmoubasher |
المؤلف | Al-Thani, Mohammed H.J. |
المؤلف | Chivese, Tawanda |
المؤلف | Emara, Mohamed M. |
تاريخ الإتاحة | 2023-05-03T09:45:09Z |
تاريخ النشر | 2023-02-20 |
اسم المنشور | Microbiology Research |
المعرّف | http://dx.doi.org/10.3390/microbiolres14010023 |
الاقتباس | AbouGalala, K., Elsayed, B., Elmarasi, M., Kotob, M., Taha, R., Abbasher, F., ... & Emara, M. M. (2023). Association between Multimorbidity and COVID-19 Mortality in Qatar: A Cross-Sectional Study. Microbiology Research, 14(1), 289-296. |
الرقم المعياري الدولي للكتاب | 2036-7473 |
الملخص | This study assessed the association between multimorbidity and mortality from COVID-19 in the Middle East and North Africa region, where such data are scarce. We conducted a cross-sectional study using data of all cases with COVID-19 reported to the Ministry of Public Health of Qatar from March to September 2020. Data on pre-existing comorbidities were collected using a questionnaire and multimorbidity was defined as having at least two comorbidities. Proportions of deaths were compared by comorbidity and multimorbidity status and multivariable logistic regression analyses were carried out. A total of 92,426 participants with a mean age of 37.0 years (SD 11.0) were included. Mortality due to COVID-19 was associated with gastrointestinal diseases (aOR 3.1, 95% CI 1.16–8.30), respiratory diseases (aOR 2.9, 95% CI 1.57–5.26), neurological diseases (aOR 2.6, 95% CI 1.19–5.54), diabetes (aOR 1.8, 95% CI 1.24–2.61), and CVD (aOR 1.5, 95% CI 1.03–2.22). COVID-19 mortality was strongly associated with increasing multimorbidity; one comorbidity (aOR 2.0, 95% CI 1.28–3.12), two comorbidities (aOR 2.8, 95% CI 1.79–4.38), three comorbidities (aOR 6.0, 95% 3.34–10.86) and four or more comorbidities (aOR 4.15, 95% 1.3–12.88). This study demonstrates a strong association between COVID-19 mortality and multimorbidity in Qatar. |
اللغة | en |
الناشر | PagePress |
الموضوع | chronic diseases comorbidities COVID-19 Middle East and North Africa mortality multimorbidity pre-existing diseases SARS-CoV-2 |
النوع | Article |
الصفحات | 289-296 |
رقم العدد | 1 |
رقم المجلد | 14 |
ESSN | 2036-7481 |
الملفات في هذه التسجيلة
هذه التسجيلة تظهر في المجموعات التالية
-
أبحاث فيروس كورونا المستجد (كوفيد-19) [799 items ]
-
أبحاث الطب [1382 items ]